An intrinsically labile α-helix abutting the BCL9-binding site of β-catenin is required for its inhibition by carnosic acid

Citations Over TimeTop 10% of 2012 papers

Abstract

Wnt/β-catenin signalling controls development and tissue homeostasis. Moreover, activated β-catenin can be oncogenic and, notably, drives colorectal cancer. Inhibiting oncogenic β-catenin has proven a formidable challenge. Here we design a screen for small-molecule inhibitors of β-catenin's binding to its cofactor BCL9, and discover five related natural compounds, including carnosic acid from rosemary, which attenuates transcriptional β-catenin outputs in colorectal cancer cells. Evidence from NMR and analytical ultracentrifugation demonstrates that the carnosic acid response requires an intrinsically labile α-helix (H1) amino-terminally abutting the BCL9-binding site in β-catenin. Similarly, in colorectal cancer cells with hyperactive β-catenin signalling, carnosic acid targets predominantly the transcriptionally active ('oncogenic') form of β-catenin for proteasomal degradation in an H1-dependent manner. Hence, H1 is an 'Achilles' Heel' of β-catenin, which can be exploited for destabilization of oncogenic β-catenin by small molecules, providing proof-of-principle for a new strategy for developing direct inhibitors of oncogenic β-catenin.

Related Papers

• → Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3–independent β-catenin degradation(2003)718 cited
• → A New Look at TCF and β-Catenin through the Lens of a Divergent C. elegans Wnt Pathway(2009)119 cited
• → β catenin in health: A review(2015)25 cited
• → Protein Kinases Involved in the Regulation of Wnt/β-catenin Signaling(2013)5 cited
• Wnt／β-catenin 信号通路4个基因在子宫内膜异位症中的表达及意义(2014)